EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Synbiotic of Lacto-N-tetraose and Bifidobacterium animalis subsp. lactis MN-Gup Attenuates High-Fat Diet-Induced Obesity by Modulating Metabolism and Gut Microbiota in Mice

Ying Luo iD, Yang Li, Linjun Wu, Xiaoqiong Li iD, Xiangyu Bian iD, Jian Kuang iD, Jianqiang Li iD, Fangshu Shi, Xuguang Zhang, Xiaoqiang Han, Jinzhu Pang, Jinjun Li iD und 1 weitere

Nutrients · 24.05.2026 · 18 (11) · 1681

DOI: 10.3390/nu18111681 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 24.05.2026. Verfasst von Ying Luo und 12 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College, Shanxi Medical University, Taiyuan 030000, China. Hauptthemen laut MEDLINE: Diet, High-Fat, Obesity, Gastrointestinal Microbiome, Synbiotics. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Shanxi Province Science and Technology Cooperation and Exchange Special Project, the "Pioneer" and "Leading Goose" R&D Program of Zhejiang, Shanxi Province Science and Technology Cooperation and Exchange Special Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Obesity is closely associated with gut microbiota dysbiosis, intestinal barrier dysfunction, and impaired glucose and lipid metabolism. However, single probiotic or prebiotic interventions often yield only limited metabolic improvements. This study aimed to evaluate the effects of a synbiotic formulation comprising Lacto-N-tetraose (LNT) and Bifidobacterium animalis subsp. lactis MN-Gup (MN-Gup) in a high-fat diet (HFD)-induced obese mouse model.

Methods

In this study, an HFD-induced obese mouse model was used to investigate whether the synbiotic formulation of LNT and MN-Gup could ameliorate obesity-related metabolic dysregulation, intestinal barrier dysfunction, and gut microbiota imbalance. Mice were treated with LNT alone, MN-Gup alone, or the synbiotic at different doses. Serum biochemical parameters, glucose tolerance, lipid profiles, liver histopathology, intestinal barrier markers, gut microbiota composition, short-chain fatty acid (SCFA) levels were analyzed.

Results

High-dose synbiotic intervention significantly outperformed single-component treatments in reducing weight gain, improving glucose tolerance and lipid profiles, and attenuating hepatic lipid accumulation and injury in mice. These metabolic changes were accompanied by improved markers of intestinal barrier integrity and modulation of gut microbiota composition, characterized by the enrichment of beneficial genera (e.g., Akkermansia, Leuconostoc, and Alistipes) alongside a reduction in obesity-associated taxa (including Desulfovibrionaceae_unclassified, Colidextribacter, Helicobacter, Erysipelatoclostridium, Peptococcaceae_unclassified, and Firmicutes_unclassified). Spearman correlation analysis revealed associative links between microbial alterations and host metabolic markers.

Conclusions

Collectively, these findings suggest that the synbiotic formulation comprising high-dose LNT and MN-Gup offers potential benefits for managing high-fat diet-induced metabolic dysregulation in mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, High-FatObesityGastrointestinal MicrobiomeSynbioticsBifidobacterium animalisAnimalsMaleMiceMice, Inbred C57BLLipid MetabolismIntestinal Barrier FunctionDisease Models, AnimalLiverBlood Glucose

Stichwörter der Autor:innen

Bifidobacterium animalis subsp. lactis MN-GupLacto-N-tetraosegut microbiotaobesitysynbiotics

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • First Clinical Medical College, Shanxi Medical University, Taiyuan 030000, China.
  • State Key Laboratory for Quality and Safety of Agro-Products, Institute of Food Sciences, Zhejiang Academy of Agricultural Sciences, Hangzhou 310021, China.
  • Academy of Medical Sciences, Shanxi Medical University, Taiyuan 030000, China.
  • Mengniu Institute of Nutrition Science, Global R&D Innovation Center, Inner Mongolia Mengniu Dairy (Group) Co., Ltd., Beijing 101107, China.

ORCID-Profile: Ying Luo, Xiaoqiong Li, Xiangyu Bian, Jian Kuang, Jianqiang Li, Jinjun Li

Förderung

  • the Shanxi Province Science and Technology Cooperation and Exchange Special Project
  • the "Pioneer" and "Leading Goose" R&D Program of Zhejiang
  • Shanxi Province Science and Technology Cooperation and Exchange Special Project
  • “Pioneer” and “Leading Goose” R&D Program of Zhejiang

Zitieren

APA

Luo, Y., Li, Y., Wu, L., Li, X., Bian, X., Kuang, J., Li, J., Shi, F., Zhang, X., Han, X., Pang, J., Li, J., & Sun, H. (2026). A Synbiotic of Lacto-N-tetraose and Bifidobacterium animalis subsp. lactis MN-Gup Attenuates High-Fat Diet-Induced Obesity by Modulating Metabolism and Gut Microbiota in Mice. Nutrients, 18(11), 1681. https://doi.org/10.3390/nu18111681

Vancouver

Luo Y, Li Y, Wu L, Li X, Bian X, Kuang J, et al. A Synbiotic of Lacto-N-tetraose and Bifidobacterium animalis subsp. lactis MN-Gup Attenuates High-Fat Diet-Induced Obesity by Modulating Metabolism and Gut Microbiota in Mice. Nutrients. 2026;18(11):1681. doi:10.3390/nu18111681

BibTeX
@article{Luo2026,
  author = {Luo, Ying and Li, Yang and Wu, Linjun and Li, Xiaoqiong and Bian, Xiangyu and Kuang, Jian and Li, Jianqiang and Shi, Fangshu and Zhang, Xuguang and Han, Xiaoqiang and Pang, Jinzhu and Li, Jinjun and Sun, Haibiao},
  title = {A Synbiotic of Lacto-N-tetraose and Bifidobacterium animalis subsp. lactis MN-Gup Attenuates High-Fat Diet-Induced Obesity by Modulating Metabolism and Gut Microbiota in Mice},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {1681},
  doi = {10.3390/nu18111681}
}
Kostenlos starten →